Novalar Pharmaceuticals

About:

Novalar Pharmaceuticals develops oral pharmaceutical products, focusing on dental products such as OraVerse.

Website: http://www.novalarpharm.com/

Top Investors: New Enterprise Associates, Boston Millennia Partners, SR One, Domain Associates, Montreux Equity Partners

Description:

Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.